Search

Search results

717 results found

Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trials.

Langley, R G, A B Kimball, H Nak, W Xu, B Pangallo, O O Osuntokun, N Agada, and K Reich. 2019. “Long-Term Safety Profile of Ixekizumab in Patients With Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis from 11 Clinical Trials.”. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (2): 333-39.

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.

Garg, Amit, Neeta Malviya, Andrew Strunk, Shari Wright, Afsaneh Alavi, Raed Alhusayen, Ali Alikhan, et al. 2022. “Comorbidity Screening in Hidradenitis Suppurativa: Evidence-Based Recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.”. Journal of the American Academy of Dermatology 86 (5): 1092-1101.

Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.

Kimball, Alexa B, Murali Sundaram, Benjamin Banderas, Catherine Foley, and Alan L Shields. 2018. “Development and Initial Psychometric Evaluation of Patient-Reported Outcome Questionnaires to Evaluate the Symptoms and Impact of Hidradenitis Suppurativa.”. The Journal of Dermatological Treatment 29 (2): 152-64.